Dr Martens shares fall despite narrower H1 losses
By Frank Prenesti
Date: Thursday 20 Nov 2025
(Sharecast News) - British bootmaker Dr Martens narrowed first-half losses on the back of higher sales in its key Americas market and held guidance for its 2026 fiscal year despite a headwind from US tariffs.
Adjusted pre-tax losses came it at £9.2m for the six-months to September 28, compared with £16.6m last year. Americas was the best performing region with revenue up 6% with both the direct-to-consumer and wholesale channels in positive growth.
Despite the improved performance, shares in the firm were down almost 5% in early London trade amid a rising market.
The company, famed for its lace-up boots with chunky soles, said it was expecting adjusted profits in a £53m to £60m range, according to consensus forecasts and excluding the impact from tariffs.
It added that tariffs would present a high single-digit million-pound headwind and expected to offset roughly half of this impact.
"While the trading backdrop across our markets remains volatile, we are focused on executing our plans, growing profit and taking the right decisions for full-year 2027 and beyond," the company said on Thursday.
"Since the end of the first half, our Americas business has continued to deliver positive full price DTC growth. Our EMEA business continues to see variable trading and a particularly challenging performance in retail across our largest markets."
Reporting by Frank Prenesti for Sharecast.com
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN